Medicine

D. Sterlin, A. Mathian, M. Miyara

2019Rare Diseases of the Immune System

DOI: 10.1007/978-3-030-02239-6_3

tlooto Summary

Those new etiopathogenetic pathways represent promising therapeutic targets in AAV because of their capacity to promote the complement alternate activation pathway through the ligation of C5a to the C4a receptors on neutrophils.

Abstract

Abstract is not available.

Citation format

STERLIN, D.; MATHIAN, A.; MIYARA, M. Etiopathogenesis of ANCA-Associated vasculitis. Rare Diseases of the Immune System, 2019.